Retinoblastoma co-repressor 1 (RB) and cyclin-dependent kinase inhibitor (CDKN) as a multi-gene panel for differentiating pulmonary from non-pulmonary origin in metastatic neuroendocrine carcinomas

Publication date: Available online 10 June 2020Source: Pathology - Research and PracticeAuthor(s): Kritika Krishnamurthy, Mike Cusnir, Michael Schwartz, Vathany Sriganeshan, Robert J. Poppiti
Source: Pathology Research and Practice - Category: Pathology Source Type: research